- Home
- ENX vs CBUS Comparison
ENX vs CBUS Comparison
Compare ENX & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- CBUS
- Stock Information
- Founded
- ENX 2002
- CBUS 2010
- Country
- ENX United States
- CBUS United States
- Employees
- ENX N/A
- CBUS N/A
- Industry
- ENX Finance/Investors Services
- CBUS Agricultural Chemicals
- Sector
- ENX Finance
- CBUS Industrials
- Exchange
- ENX Nasdaq
- CBUS Nasdaq
- Market Cap
- ENX 178.4M
- CBUS 160.8M
- IPO Year
- ENX N/A
- CBUS 2017
- Fundamental
- Price
- ENX $9.98
- CBUS $3.88
- Analyst Decision
- ENX
- CBUS Strong Buy
- Analyst Count
- ENX 0
- CBUS 3
- Target Price
- ENX N/A
- CBUS $23.33
- AVG Volume (30 Days)
- ENX 25.4K
- CBUS 276.6K
- Earning Date
- ENX 01-01-0001
- CBUS 11-07-2024
- Dividend Yield
- ENX 3.94%
- CBUS N/A
- EPS Growth
- ENX N/A
- CBUS N/A
- EPS
- ENX 0.16
- CBUS N/A
- Revenue
- ENX N/A
- CBUS $2,961,000.00
- Revenue This Year
- ENX N/A
- CBUS $36.93
- Revenue Next Year
- ENX N/A
- CBUS $236.45
- P/E Ratio
- ENX $61.00
- CBUS N/A
- Revenue Growth
- ENX N/A
- CBUS 816.72
- 52 Week Low
- ENX $7.84
- CBUS $3.58
- 52 Week High
- ENX $10.07
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- ENX 53.45
- CBUS 30.27
- Support Level
- ENX $9.95
- CBUS $3.58
- Resistance Level
- ENX $10.08
- CBUS $5.58
- Average True Range (ATR)
- ENX 0.07
- CBUS 0.62
- MACD
- ENX 0.00
- CBUS -0.07
- Stochastic Oscillator
- ENX 52.17
- CBUS 8.31
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.